Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.41 |
| ▸ | LOX | P28300 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.37 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.37 |
| ▸ | ANPEP | P15144 | 1/20 | 0.37 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10823165 | 0.98 | POLB (0.41) | POLBSMN1; SMN2HSD17B10CXCR4LOX | |
| SCHEMBL7618304 | 0.98 | POLB (0.41) | POLBSMN1; SMN2HSD17B10CXCR4LOX | |
| Potassium Ion SCHEMBL28852047 | 0.96 | POLB (0.39) | POLBSMN1; SMN2HSD17B10CXCR4LOX | |
| Water SCHEMBL28459309 | 0.96 | POLB (0.39) | POLBSMN1; SMN2HSD17B10CXCR4LOX | |
| SCHEMBL28248770 | 0.92 | POLB (0.37) | POLBSMN1; SMN2HSD17B10CXCR4LOX | |
| Piperazine SCHEMBL28819458 | 0.91 | LMNA (0.37) | POLBSMN1; SMN2HSD17B10CXCR4LOX | |
| SCHEMBL2511955 | 0.91 | ALDH1A1 (0.37) | POLBSMN1; SMN2HSD17B10CXCR4LOX | |
| SCHEMBL1007938 | 0.91 | ALDH1A1 (0.37) | POLBSMN1; SMN2HSD17B10CXCR4LOX | |
| SCHEMBL3294493 | 0.91 | ALDH1A1 (0.37) | POLBSMN1; SMN2HSD17B10CXCR4LOX | |
| SCHEMBL1647095 | 0.88 | CXCR4 (0.47) | POLBSMN1; SMN2HSD17B10CXCR4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 907 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260077092-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | Miach Orthopaedics, Inc. (US) | 2026-03-19 | — | — | US | claimed |
| EP-4654940-A1 | ANNEALED MICROGEL PARTICLE SYSTEMS AND METHODS | Tempo Therapeutics, Inc. (US) | 2025-12-03 | — | — | EP | claimed |
| WO-2025122978-A1 | CELL CRYOPRESERVATION AND DELIVERY VEHICLE AND METHODS OF USING THE SAME | BLUEROCK THERAPEUTICS LP (US) | 2025-06-12 | — | — | WO | claimed |
| WO-2025056716-A1 | KITS AND METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES | Technische Universität München, in Vertretung des Freistaates Bayern (DE) | 2025-03-20 | — | — | WO | claimed |
| EP-4408174-A1 | OPTIMIZED WATER LINE DELIVERY OF MICROBES | International N&H Denmark ApS (DK) | 2024-08-07 | — | — | EP | claimed |
| WO-2024159142-A1 | ANNEALED MICROGEL PARTICLE SYSTEMS AND METHODS | TEMPO THERAPEUTICS, INC. (US) | 2024-08-02 | — | — | WO | claimed |
| WO-2024118032-A1 | SPERM WASHING AND SPERM FREEZING SOLUTIONS ENRICHED WITH QUERCETIN | ISTANBUL MEDIPOL UNIVERSITESI TEKNOLOJI TRANSFER OFISI ANONIM SIRKETI (TR) | 2024-06-06 | — | — | WO | claimed |
| WO-2024107917-A1 | SYNTHETIC ENAMEL AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2024-05-23 | — | — | WO | claimed |
| WO-2024057324-A1 | PLASMA-ACTIVATED COMPOSITIONS AND METHODS OF USE THEREOF | NOVA PLASMA LTD. (IL) | 2024-03-21 | — | — | WO | claimed |
| WO-2024047639-A1 | INDOLIUM-BASED STABILIZERS OF HYDROPHOBIC DRUGS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2024-03-07 | — | — | WO | claimed |
| EP-1033913-A1 | ZWITTERIONIC FATTY ACID COMPOUNDS FOR ANTI-INFLAMATION | Pugliese, Peter T. (US) | 2000-09-13 | — | — | EP | claimed |
| WO-1999051204-A1 | OCULAR IRRIGATING SOLUTION | UNIVERSITY OF BRISTOL (GB) | 1999-10-14 | — | — | WO | claimed |
| WO-1999027791-A1 | ZWITTERIONIC FATTY ACID COMPOUNDS FOR ANTI-INFLAMATION | PUGLIESE PETER T (US) | 1999-06-10 | — | — | WO | claimed |
| EP-0396584-B1 | ASSAY OF SALICYLATES OR REDUCED PYRIDINE NUCLEOTIDES | MICROBIOLOGICAL RES AUTHORITY (GB) | 1995-01-25 | — | — | EP | claimed |
| EP-0228239-B1 | PREPARATION OF A MEDICAMENT FOR ARTHRITIS AND RHEUMATISM | O'Sullivan, Donncha (IE) | 1993-07-28 | — | — | EP | claimed |
| WO-1992006383-A1 | DILUENT AND METHOD FOR DETERMINATION OF TOTAL CALCIUM | BECKMAN INSTRUMENTS, INC. (US) | 1992-04-16 | — | — | WO | claimed |
| US-4753942-A | Method for the treatment of inflammatory conditions | SULLIVAN DONNCHA O (IE) | 1988-06-28 | — | — | US | claimed |
| EP-0228239-A2 | Preparation of a medicament for arthritis and rheumatism | O'Sullivan, Donncha (IE) | 1987-07-08 | — | — | EP | claimed |
| EP-0100827-B1 | PHARMACEUTICAL COMPOSITION CONTAINING AN ALIPHATIC AMINOSULPHONIC ACID | ROSICAL LIMITED (IE) | 1986-09-03 | — | — | EP | claimed |
| EP-0100827-A1 | Pharmaceutical composition containing an aliphatic aminosulphonic acid | ROSICAL LIMITED (IE) | 1984-02-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260077092-A1 | INJECTABLE COLLAGEN IMPLANTS AND COMPOSITIONS AND RELATED SYSTEMS, AND METHODS OF PREPARATION AND USE THEREOF | COL2A1, COL1A1, MMP1 | POLB 4565/4885SMN1; SMN2 1082/4885HSD17B10 1394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.